Mark Heise
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Bone health and osteoporosis research
Papers in
-
- Metabolism, Diabetes, and Cancer 5
- Peroxisome Proliferator-Activated Receptors 5
-
- Diabetes Treatment and Management 4
- Diabetes Management and Research 2
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Co-authors
- Giancarlo Viberti (5 shared papers)Steven M. Haffner (6 shared papers)Steven E. Kahn (8 shared papers)Bernard Zinman (5 shared papers)Rury R. Holman (6 shared papers)William H. Herman (6 shared papers)John M. Lachin (7 shared papers)Barbara G. Kravitz (6 shared papers)
- Journals
- Diabetologia (4 papers)Journal of the American Society of Nephrology (2 papers)Diabetic Medicine (2 papers)Diabetes Research and Clinical Practice (2 papers)Diabetes Care (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark Heise
25 papers receiving 3.5k citations
Mark Heise's Hit Papers
Peers
Comparison fields: 5 of 97
- Endocrinology, Diabetes and Metabolism 2.1k
- Orthopedics and Sports Medicine 240
- Molecular Biology 1.5k
- Surgery 694
- Pharmacology 249
Countries citing papers authored by Mark Heise
This map shows the geographic impact of Mark Heise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Heise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Heise more than expected).
Fields of papers citing papers by Mark Heise
This network shows the impact of papers produced by Mark Heise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Heise. The network helps show where Mark Heise may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Heise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy Hit paper breakdown → | 2006 | 2299 |
| 2 | Rosiglitazone-Associated Fractures in Type 2 Diabetes Hit paper breakdown → | 2008 | 432 |
| 3 | 2003 | 203 | |
| 4 | 2002 | 202 | |
| 5 | 2004 | 151 | |
| 6 | 2006 | 88 | |
| 7 | 2004 | 58 | |
| 8 | 2005 | 54 | |
| 9 | 2015 | 46 | |
| 10 | 2006 | 36 | |
| 11 | 2008 | 34 | |
| 12 | 2000 | 29 | |
| 13 | 2022 | 15 | |
| 14 | 2022 | 13 | |
| 15 | 2002 | 11 | |
| 16 | 2000 | 8 | |
| 17 | 2011 | 6 | |
| 18 | 1995 | 6 | |
| 19 | 1996 | 5 | |
| 20 | 2024 | 4 |
About Mark Heise
Mark Heise is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Pharmacology, Genetics and Nephrology, having authored 27 papers that have together received 3.7k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Diabetes Treatment and Management (4 papers), Diabetes and associated disorders (3 papers), Diabetes Management and Research (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), MRI in cancer diagnosis (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.1k citations), Orthopedics and Sports Medicine (240 citations), Molecular Biology (1.5k citations), Surgery (694 citations) and Pharmacology (249 citations). Mark Heise has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Giancarlo Viberti, Steven M. Haffner, Steven E. Kahn, Bernard Zinman, Rury R. Holman, William H. Herman, John M. Lachin, Barbara G. Kravitz, Mark O’Neill and Nigel C. Jones. Their work appears in journals such as Diabetologia, Journal of the American Society of Nephrology, Diabetic Medicine, Diabetes Research and Clinical Practice and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.